North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 2017 - MarketsandMarkets

North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 2017

North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 2017 - MarketsandMarkets
North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 2017
Published Jul 12, 2013
267 pages — Published Jul 12, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future.

The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017. Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injectable, transdermal, implantable, ocular, nasal, transmucosal, and topical. In 2012, oral drug delivery segment dominated the market with a share of approximately 38%, followed by pulmonary drug delivery segment with a 20% share.

The drug delivery technologies that have recently gained importance in the North American market include orodispersible tablet (ODT), dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets; controlled release is the most widely accepted technology. The use of implantable devices for drug delivery is also on a rise.

Big pharmaceutical companies such as Pfizer and Merck have established in-house capabilities for the development of drug delivery technologies. On the contrary, many other companies are still relying on specialty companies engaged in the development of drug delivery technologies. High level of competition and increasing need for outsourcing has resulted in the drug delivery market to be fragmented, with several small companies developing novel drug delivery technologies for niche therapeutic applications.

The North American drug delivery market is largely dominated by the U.S. (accounting for about 89% of the overall market). The key drivers for the U.S. drug delivery market are the well established pharmaceutical industry , healthcare reforms, and favourable changes in the FDA review process. Factors such as low cost drug manufacturing and rising number of drug delivery formulations and devices are propelling the Canadian market.

Key players in the drug delivery technologies market are 3M Company (U.S.), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton, Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.) and Valeant Pharmaceuticals (Canada).

Scope of the Report

This research report categorizes and analyzes the North American Drug Delivery Technologies market on the basis of routes of administration. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (U.S and Canada), to provide in-depth information on the North American market scenario.

North American drug delivery technologies market, by segment:

Oral Drug Delivery
Controlled Release
Orodispersible Tablets (ODT) and Taste Masking
Others
Pulmonary Drug Delivery
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Transdermal Drug Delivery
Passive Drug Delivery
Reservoir System
Matrix System
Active Drug Delivery
Iontophoresis
Microporation
Others
Injectable Drug Delivery
Conventional Injection Devices
Fillable Syringes
Prefilled Syringes
Self-injecti

  
Source:
Document ID
BT 2077
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table of Contents

1 Introduction (Page No. - 22)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. - 29)

3 Market Overview (Page No. - 33)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Patent Cliff And Increased Competition To Increase Adoption Rate
3.3.1.2 Improving Patient Compliance And Acceptability, An Impetus To The Drug Delivery Systems Market
3.3.1.3 Increasing Focus On Pediatric And Geriatric Patients To Boost The Growth
3.3.1.4 Increasing Incidence Of Chronic Diseases In North America To Enhance Demand
3.3.2 Restraints
3.3.2.1 Drug Failures And Recalls Mar Market Growth
3.3.2.2 Technical Barriers Restrict Growth
3.3.3 Opportunities
3.3.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms
3.3.3.2 Self-Administration And Home Care Drug Delivery Devices
3.3.3.3 Expanding Therapeutic Applications Of Drug Delivery Technologies
3.3.4 Targeted Drug Delivery
3.3.4.1 Passive Systems Contribute 60% To The Targeted Drug Delivery Market
3.3.4.2 Active Targeted Drug Delivery Has Major Applications In Cancer Therapy
3.3.4.3 Companies Focus On Novel Targeted Drug Delivery
3.3.5 Burning Issues
3.3.5.1 Striking Right Partnerships
3.3.5.2 Improving The Bioavailability Of Drugs
3.4 Regulatory Environment
3.4.1 Stringent Regulations For Pharmaceutical Drugs In North America
3.4.1.1 The Approval Process Is Complex, Time-Consuming, And Expensive
3.4.2 Effect Of The U.S. Healthcare Reforms On The Drug Delivery Industry
3.4.2.1 Drug Delivery Companies To Benefit From The Affordable Care Act (Aca) Reform In The Long Run
3.4.3 Regulations Related To The Approval Of Controlled Release Drugs
3.5 Porter's Five Forces Analysis
3.5.1 Threat Of New Entrants
3.5.2 Threat Of Substitutes
3.5.3 Competitor's Rivalry
3.5.4 Bargaining Power Of Suppliers
3.5.5 Bargaining Power Of Buyers
3.6 Value Chain Analysis
3.7 Market Share Analysis
3.7.1 Pulmonary Drug Delivery
3.7.1.1 U.S.
3.7.1.2 Canada
3.7.2 Transdermal Drug Delivery
3.7.2.1 U.S.
3.7.2.2 Canada
3.7.3 Inectable Drug Delivery Devices
3.7.3.1 U.S.
3.7.3.2 Canada
3.7.4 Implantable Drug Delivery
3.7.4.1 U.S.
3.7.4.2 Canada
3.7.5 Other Drug Delivery Segments

4 North America Drug Delivery Market, By Technology (Page No. - 65)
4.1 Introduction
4.1.1 Drug Delivery Market Witnessing Technological Advancements
4.2 Opportunity Matrix
4.3 Oral Drug Delivery
4.3.1 Reformulation Strategies & Establishing In-House Capabilities Help In Significant Growth
4.3.2 Controlled Release
4.3.3 Orodispersible Tablets (ODT) And Taste Masking
4.3.4 Others
4.4 Pulmonary Drug Delivery
4.4.1 Therapeutic Applications Of Pulmonary Delivery
4.4.1.1 Application Of Pulmonary Delivery For Non-Respiratory Therapies

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 2017" Jul 12, 2013. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/North-American-Drug-Delivery-Technologies-Market-Metered-Dose-Inhalers-Needle-Free-Injectors-Auto-Injectors-Nasal-Sprays-Transdermal-Patches-Nebulizers-Infusion-Pumps-Drug-Eluting-Stents-Sustained-Release-Ocular-Implants-Forecasts-To-2017-2144-184>
  
APA:
MarketsandMarkets. (2013). North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 2017 Jul 12, 2013. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/North-American-Drug-Delivery-Technologies-Market-Metered-Dose-Inhalers-Needle-Free-Injectors-Auto-Injectors-Nasal-Sprays-Transdermal-Patches-Nebulizers-Infusion-Pumps-Drug-Eluting-Stents-Sustained-Release-Ocular-Implants-Forecasts-To-2017-2144-184>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.